Cargando…
Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer
Epidermal growth factor receptor (EGFR) signalling and the interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) are aberrantly activated in ovarian cancer. However, inhibition of EGFR signalling in ovarian cancer patients resulted in a disappointing clinical benefit. In th...
Autores principales: | Yan, Meina, Han, Mutian, Yang, Xinxin, Shen, Rong, Wang, Hui, Zhang, Lubin, Xia, Sheng, Yang, Peifang, Zhai, Guanghua, Shao, Qixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354159/ https://www.ncbi.nlm.nih.gov/pubmed/34369236 http://dx.doi.org/10.1080/14756366.2021.1963240 |
Ejemplares similares
-
miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer
por: Yan, Meina, et al.
Publicado: (2018) -
High LIN28A and PLK4 co-expression is associated with poor prognosis in epithelial ovarian cancer
por: He, Yao, et al.
Publicado: (2018) -
MiR-146a upregulates FOXP3 and suppresses inflammation by targeting HIPK3/STAT3 in allergic conjunctivitis
por: Guo, Hui, et al.
Publicado: (2022) -
Identifying miRNA-mRNA regulation network of major depressive disorder in ovarian cancer patients
por: Wu, Chengjiang, et al.
Publicado: (2018) -
STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b
por: Walker, Sarah R., et al.
Publicado: (2014)